Invention Grant
- Patent Title: Quinazoline carboxamide azetidines
- Patent Title (中): 喹唑啉羧酰胺氮杂环丁烷
-
Application No.: US13989199Application Date: 2011-11-11
-
Publication No.: US08946247B2Publication Date: 2015-02-03
- Inventor: Bayard R. Huck , Reinaldo Jones , Yufang Xiao , Constantin Neagu , Donald Bankston , Andreas Goutopoulos
- Applicant: Bayard R. Huck , Reinaldo Jones , Yufang Xiao , Constantin Neagu , Donald Bankston , Andreas Goutopoulos
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- International Application: PCT/EP2011/005691 WO 20111111
- International Announcement: WO2012/069146 WO 20120531
- Main IPC: A61K31/517
- IPC: A61K31/517 ; C07D239/72
Abstract:
The invention provides novel quinazoline carboxamide azetidine compounds according to Formula (I) and use for the treatment of hyperproliferative diseases, such as cancer.
Public/Granted literature
- US20130252942A1 QUINAZOLINE CARBOXAMIDE AZETIDINES Public/Granted day:2013-09-26
Information query
IPC分类:
